(VIANEWS) – ClearBridge Energy MLP Fund (CEM), Western Asset Bond Fund Share of Beneficial Interest (WEA), Babson Capital Corporate Investors (MCI) have the highest dividend yield stocks on this list.

Rank Financial Asset Price Change Forward Dividend Yield Updated (EST)
1 ClearBridge Energy MLP Fund (CEM) 32.77 1.96% 7.67% 2022-08-08 09:08:06
2 Western Asset Bond Fund Share of Beneficial Interest (WEA) 11.59 0.7% 6.88% 2022-08-12 19:06:12
3 Babson Capital Corporate Investors (MCI) 14.56 0.76% 6.64% 2022-08-10 13:10:07
4 Merck (MRK) 90.87 2.18% 3.09% 2022-08-14 08:15:56

A little less 2K companies listed in the Nasdaq and NYSE pay out dividends to its shareholders. The dividend yield is a dividend to price ratio showing how much a company pays out in dividends each year.

1. ClearBridge Energy MLP Fund (CEM) – Dividend Yield: 7.67%

ClearBridge Energy MLP Fund Inc., a closed-ended equity mutual funds, was launched by Legg Mason Partners Fund Advisor, LLC. Clearbridge Advisors, LLC co-manages the fund. It invests in American public equity markets. The fund invests in stock of energy-related companies. It invests primarily in equity securities of MLPs as well growth stocks from companies with diversified market capitalizations. The fund uses fundamental analysis and a top-down stock selection strategy to build its portfolio. It focuses on long-lasting assets with predictable cash flows and low commodity exposure. ClearBridge Energy MLP Fund Inc., which was established on March 31, 2010, is based in the United States.

Volume

Today’s last reported volume for ClearBridge Energy MLP Fund is 3656, 94.67% below its average volume of 68653.

ClearBridge Energy MLP Fund’s last close was $32.14, 15.4% under its 52-week high of $37.99.

ClearBridge Energy MLP Fund’s Stock Yearly Top and Bottom Value

ClearBridge Energy MLP Fund’s stock is valued at $32.77 at 03:15 EST, way under its 52-week high of $37.99 and way higher than its 52-week low of $24.65.

ClearBridge Energy MLP Fund’s Moving Average

ClearBridge Energy MLP Fund’s value is higher than its 50-day moving average of $31.71 and higher than its 200-day moving average of $31.03.

More news about ClearBridge Energy MLP Fund.

2. Western Asset Bond Fund Share of Beneficial Interest (WEA) – Dividend Yield: 6.88%

Western Asset Management Company launched the Western Asset Premier Bond Fund, a fixed-income mutual fund that is closed-ended and manages it. Western Asset Management Company Limited and Western Asset Management Company Pte co-manage the fund. Ltd. and Western Asset Management Company Ltd. The fund invests in fixed income markets within the United States. It invests primarily in investment-grade bonds including U.S. agency and corporate securities and securities related to mortgages. The fund aims to have a average tenure of two to three years and a credit quality of at least BBB. It benchmarks its portfolio performance against both the Barclays Capital U.S. Corporate High Yield Index (Barclays Capital U.S. Credit Index) and the Barclays Capital U.S. Credit Index. The Western Asset Premier Bond Fund, which was established on March 28, 2002, is based in the United States.

Volume

Today’s last reported volume for Western Asset Bond Fund Share of Beneficial Interest is 19171, 27.97% below its average volume of 26614.

Western Asset Bond Fund Share of Beneficial Interest’s last close was $11.59, 21.48% below its 52-week high of $14.76.

Western Asset Bond Fund Share of Beneficial Interest’s Revenue

Year-on-year quarterly revenue growth declined by 1.6%, now sitting on 12.4M for the twelve trailing months.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Western Asset Bond Fund Share of Beneficial Interest’s stock is considered to be oversold (<=20).

Western Asset Bond Fund Share of Beneficial Interest’s Stock Yearly Top and Bottom Value

Western Asset Bond Fund Share of Beneficial Interest’s stock is valued at $11.59 at 03:15 EST, way under its 52-week high of $14.76 and way higher than its 52-week low of $10.40.

Western Asset Bond Fund Share of Beneficial Interest’s Moving Average

Western Asset Bond Fund Share of Beneficial Interest’s worth is higher than its 50-day moving average of $10.88 and under its 200-day moving average of $12.28.

More news about Western Asset Bond Fund Share of Beneficial Interest.

3. Babson Capital Corporate Investors (MCI) – Dividend Yield: 6.64%

Babson Capital Corporate Investors Trust is closed-ended fixed income mutual fund that was launched by Barings LLC. The fund invests in the fixed income markets of America. It invests in securities from companies that operate across diverse sectors. The fund invests primarily in privately-placed, low-investment-grade, long-term corporate debt obligations. It also invests marketable, investment-grade debt securities and other marketable securities. It used to be known previously as Babson Capital Corporation Investors. Babson Capital Corporate Investors Trust was established in 1971. It is based in the United States.

Volume

Today’s last reported volume for Babson Capital Corporate Investors is 15670, 31.57% below its average volume of 22898.

Babson Capital Corporate Investors’s last close was $14.45, 13.94% below its 52-week high of $16.79.

Babson Capital Corporate Investors’s Revenue

Year-on-year quarterly revenue growth grew by 3.8%, now sitting on 25.98M for the twelve trailing months.

Babson Capital Corporate Investors’s Stock Yearly Top and Bottom Value

Babson Capital Corporate Investors’s stock is valued at $14.56 at 03:16 EST, way below its 52-week high of $16.79 and higher than its 52-week low of $13.32.

Babson Capital Corporate Investors’s Moving Average

Babson Capital Corporate Investors’s value is above its 50-day moving average of $13.85 and below its 200-day moving average of $15.05.

More news about Babson Capital Corporate Investors.

4. Merck (MRK) – Dividend Yield: 3.09%

Merck & Co., Inc. offers healthcare solutions around the world. Merck & Co., Inc. offers preventive and therapeutic agents for type 2 diabetes, cardiovascular disease, HIV-1, HIV-1, intra-abdominal fungal infection and insomnia; neuromuscular blockers; cholesterol modifying medications; anti-bacterial contraceptive products; and vaginal contraceptive solutions. The company offers products that prevent post-operative and chemotherapy-induced nausea and vomiting, treat small-cell lung and non-small cell breast cancers and diseases such as esophageal and thyroid problems, brain, cervical and ovarian cancers and vaccines against measles and mumps. The company also offers anti-inflammatory and antibiotic drugs for respiratory and infectious diseases and fertility disorders. It has vaccines for chickens. It also offers companion animals, diabetes management and anti-helmintic products, as well as products that treat ticks and mosquitoes. The company also offers solutions and services that are focused on health analytics, engagement, clinical and clinical care. Merck & Co., Inc. collaborates with AstraZeneca PLC, Bayer AG, Eisai Co., Ltd., Almac Discovery Ltd., Skyhawk Therapeutics, Inc., Ridgeback Biotherapeutics, Shanghai Junshi Biosciences Co., Ltd., and FUJIFILM Corp. The company serves pharmacies, government agencies, drug wholesalers, retailers, hospitals and other health care providers, as well as physicians, physician distributors, vets, animal producers, and managed health insurance providers. It was established in 1891, and its headquarters is in Kenilworth in New Jersey.

Volume

Today’s last reported volume for Merck is 6340340, 42.38% below its average volume of 11004500.

Merck’s last close was $91.02, 4.91% under its 52-week high of $95.72.

The company’s growth estimates for the present quarter is 6.3% and a drop 10% for the next.

Merck’s Revenue

Year-on-year quarterly revenue growth grew by 28%, now sitting on 57.17B for the twelve trailing months.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Merck’s stock is considered to be oversold (<=20).

Merck’s Stock Yearly Top and Bottom Value

Merck’s stock is valued at $90.87 at 03:16 EST, under its 52-week high of $95.72 and way above its 52-week low of $70.89.

Merck’s Moving Average

Merck’s worth is higher than its 50-day moving average of $90.15 and above its 200-day moving average of $83.80.

More news about Merck.

LEAVE A REPLY

Please enter your comment!
Please enter your name here